$BWIN

Baldwin Group reports Q3 revenue up 31% to $480.3 million

Baldwin Insurance Group (NASDAQ:BWIN) reported Q3 revenue of $480.3M, up 31% YoY, with organic growth of 6%. Net loss was $81.6M, wider than the $30.2M loss last year. Adjusted EBITDA grew 47% to $106.9M. The company agreed to be acquired for $32.50 per share, expected to close in Q1 2027.

Original reporting
Published Oct 27, 2026, 1:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 1:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$BWIN
Bullish
high confidence
Mentioned
$BWIN
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BWINBullishHigh
01

Why it matters

The acquisition price offers a premium to current market levels, likely driving short‑term buying pressure.

02

Market read

The merger announcement is the primary catalyst for BWIN, creating immediate trading opportunity.

03

What to watch

Potential debt refinancing needs and integration risks post‑acquisition may affect long‑term value.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

BWIN reported preliminary Q3 results showing revenue growth but a widening net loss, followed by the merger announcement.

Company-level read

Ticker impact

$BWINBullishHigh confidence
Context

BWIN disclosed a definitive merger agreement to be acquired at $32.50 per share, a new primary M&A event.

Expected impact

likely upside as the market prices in the $32.50 per share cash offer

Evidence & confidence

Buyout offers typically generate buying pressure, especially when the premium exceeds current trading levels.

Market effects

The deal highlights consolidation in the insurance distribution sector, potentially prompting valuation reassessments for peers.

Limited to U.S. markets; no broader regional effect anticipated.

Minimal global impact beyond sector-specific investors.

Counterpoint

If the deal faces regulatory or shareholder hurdles, the stock could experience volatility and downside.

Key entities

  • Baldwin Insurance Group, Inc.

    U.S. insurance distribution firm reporting Q3 results and merger agreement.

  • Sequence Holdings

    Lead investor group acquiring BWIN.

Related articles

$BWINMedAI 9/10

THE BALDWIN GROUP ANNOUNCES PRELIMINARY THIRD QUARTER 2026 RESULTS

Baldwin Insurance Group, Inc. (BWIN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 THE BALDWIN GROUP ANNOUNCES PRELIMINARY THIRD QUARTER 2026 RESULTS — Third Quarter Total Revenue Growth of 31% to $480.3 Million — — Third Quarter Net Loss of $81.6 Million; Adjusted EBITDA (1) Growth of 47% to $106.9 Million — — Third Quarter Net Loss Margin of 17%;

$BWINHighAI 9/10

UBS downgrades Baldwin Insurance stock rating on buyout deal

UBS downgraded Baldwin Insurance (NASDAQ:BWIN) to Neutral, lowering its price target to $32.50. The company agreed to a $32.50 per share take-private deal led by Sequence Holdings and Michael Dell’s family office, implying an enterprise value of $7.7B. The stock has surged 42% over six months. Baldwin's Q2 2026 EPS beat estimates, but revenue missed, and it lowered its full-year growth outlook.

$BWINMedAI 9/10

Baldwin (BWIN) Agrees to a $7.7 Billion Buyout. How Much Upside Remains for Shareholders?

The Baldwin Insurance Group (BWIN) agreed to a $7.7 billion buyout by DFO Management and Sequence Holdings, offering shareholders $32.50 per share, an 88% premium. Baldwin's Q2 revenue grew 30% to $492.9 million, with adjusted EBITDA up 37%. The deal, pending approvals, is expected to close in Q1 2027, providing immediate value but limiting future upside for public investors.

$BWINMed

Michael Dell Just Made a $7.7 Billion Bet on This Insurance Stock

Michael Dell is acquiring Baldwin & Co. (BWIN) for $7.7B. Baldwin reported Q2 revenue of $492.9M (+30% YoY), adjusted net income of $68.5M, and adjusted EBITDA of $116.7M (+37%). Management guided Q3 revenue to $485M-$495M and full-year revenue to $2.01B-$2.05B. Analysts have mixed targets, with a consensus 'Moderate Buy' and average target of $33.